查找临床试验
已按「食管癌」检索，对应国际通用词 esophageal cancer
共找到 548 项正在招募的试验
数据更新于 00:22，每 5 分钟自动同步正在招募不适用中国有中心NCT06019455
The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
China
年龄 18 Years – 75 Years
Sun Yat-sen University
正在招募不适用NCT00288119
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
United States
年龄 18 Years – 不限
Case Western Reserve University
正在招募I 期 / II 期NCT03556228
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
United States、Puerto Rico
年龄 18 Years – 80 Years
VM Oncology, LLC
正在招募I 期 / II 期中国有中心NCT06780111
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
United States、Brazil、Chile、China、Czechia 等 12 国
年龄 18 Years – 不限
Merck Sharp & Dohme LLC
正在招募I 期 / II 期中国有中心NCT07367516
Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
China
年龄 18 Years – 75 Years
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
正在招募II 期中国有中心NCT07692204
A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer
China
年龄 18 Years – 不限
Sanofi
正在招募II 期中国有中心NCT05738434
Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC
China
年龄 18 Years – 75 Years
The First Affiliated Hospital of Zhengzhou University
正在招募I 期 / II 期中国有中心NCT05937438
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
China
年龄 18 Years – 75 Years
Anhui Provincial Hospital
正在招募I 期 / II 期NCT06943521
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
United States、Japan
年龄 18 Years – 不限
Tanabe Pharma America, Inc.
正在招募不适用NCT06794125
An Evaluation of Dose-escalation for Intrathoracic Tumours
Canada
年龄 18 Years – 不限
Chris Goodman
正在招募不适用NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
United States
年龄 不限 – 不限
Sanford Health
正在招募II 期中国有中心NCT06843889
A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma
China
年龄 18 Years – 75 Years
Nanfang Hospital, Southern Medical University